Cumulative update on pregnancy outcomes after fingolimod treatment in patients with multiple sclerosis

被引：0
|
作者：
Prach, L. M. [1 ]
Moore, A. [1 ]
Rezaallah, B. [1 ]
Mcbride, G. [1 ]
Khan, I. A. [2 ]
Guennec, M. [3 ]
Bhatt, A. [2 ]
Geissbuehler, Y. [1 ]
Leon, S. Lopez [4 ]
Vukusic, S. [5 ]
Butzkueven, H. [6 ]
Tilson, H. [7 ]
Macdonald, T. M. [8 ]
Hellwig, K. [9 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[3] IQVIA, Paris, France
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Hosp Civils Lyon, Hop Neurol, Serv Neurol, Sclerose Plaques Pathol Myeline & Neuroinflammat, Lyon, France
[6] Monash Univ, MS & Neuroimmunol Unit, Cent Clin Sch, Alfred Ctr, Clayton, Vic, Australia
[7] UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[8] Ninewells Hosp & Med Sch, Dundee, Scotland
[9] Ruhr Univ, St Josef Hosp, Dept Neurol, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1118
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [31] Skin Warts during Fingolimod Treatment in Patients with Multiple Sclerosis
    Yamout, Bassem
    Jaafar, Nesreen
    Zeineddine, Maya
    NEUROLOGY, 2019, 92 (15)
  • [32] Persistent Headache in Patients With Multiple Sclerosis Starting Treatment With Fingolimod
    Fragoso, Yara Dadalti
    Adoni, Tarso
    Gomes, Sidney
    Magno Goncalves, Marcus Vinicius
    da Cunha Matta, Andre Palma
    Mendes, Maria Fernanda
    Siquineli, Fabio
    HEADACHE, 2015, 55 (04): : 578 - 579
  • [33] Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients
    Quirant-Sanchez, Bibiana
    Hervas-Garcia, Jose V.
    Teniente-Serra, Aina
    Brieva, Luis
    Moral-Torres, Ester
    Cano, Antonio
    Munteis, Elvira
    Mansilla, Maria J.
    Presas-Rodriguez, Silvia
    Navarro-Barriuso, Juan
    Ramo-Tello, Cristina
    Martinez-Caceres, Eva M.
    CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (12) : 1175 - 1184
  • [34] Skin warts during fingolimod treatment in patients with multiple sclerosis
    Jaafar, Nesreen
    Zeineddine, Maya
    Massouh, Joelle
    Yamout, Bassem I.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [35] Is fingolimod an advancement in treatment of multiple sclerosis?
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (03) : 383 - 386
  • [36] Pregnancy and multiple sclerosis: an update
    Varyte, Guoda
    Arlauskiene, Audrone
    Ramasauskaite, Diana
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (05) : 378 - 383
  • [37] Cerebrovascular Reactivity in Patients with Multiple Sclerosis Related to Fingolimod Treatment
    Uzuner, Nevzat
    Uzuner, Gulnur
    NEUROLOGY, 2020, 94 (15)
  • [38] Fingolimod for the treatment of relapsing multiple sclerosis
    Jeffery, Douglas R.
    Markowitz, Clyde E.
    Reder, Anthony T.
    Weinstock-Guttman, Bianca
    Tobias, Kathy
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (02) : 165 - 183
  • [39] Fingolimod for the treatment of relapsing multiple sclerosis
    Singer, Barry A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (06) : 589 - 602
  • [40] Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment A Cumulative 29-Year Safety Update
    Brin, Mitchell F.
    Kirby, Russell S.
    Slavotinek, Anne
    Adams, Aubrey Manack
    Parker, Lori
    Ukah, Ahunna
    Radulian, Lavinia
    Elmore, Monica R. P.
    Yedigarova, Larisa
    Yushmanova, Irina
    NEUROLOGY, 2023, 101 (02) : E103 - E113
12345